Physician profile
Ankush Bhatia
NPI 1225394802
$7,480.93
in general payments reported to CMS, 2019-2025
7 companies · $5,520 in 2025
The $5,520 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2024: $1,777 · 2025: $5,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,099 · Honoraria: $500 · Travel and Lodging: $438 · Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,099.00 |
| Honoraria | $500.00 |
| Travel and Lodging | $437.88 |
| Food and Beverage | $259.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvation Bio INC. | $4,999.00 | 2025 | |
| Alexion Pharmaceuticals, INC. | $1,680.02 | 2024 | Koselugo |
| Telix Pharmaceuticals | $596.52 | 2024-2025 | Illuccix |
| Agios Pharmaceuticals, INC. | $184.60 | 2019 | |
| Servier Pharmaceuticals LLC | $20.79 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankush Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.